Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta

Low-density lipoprotein cholesterol (LDL-C) is an important indicator in the development and management of atherosclerotic cardiovascular disease (ASCVD). Herein, we describe the management of LDL-C with lipid-lowering therapy, among patients diagnosed with clinical ASCVD in Alberta, Canada.

Year of Publication: 2019

Authors: Guanmin Chen, Megan Farris, Ming-Hui Tai, Raina Rogoza, Stephen Colgan, Tara Cowling, Todd Anderson

Journal Title: Canadian Journal of Cardiology